EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Unusual Presentation of Triple-Negative Breast Cancer in a Young Woman with Xeroderma Pigmentosum: A Case Report

Bashaer Alsaati, Reem Ujaimi, Noura Trabulsi, Atlal Abusanad

Case Reports in Oncology · 14.07.2026 · 19 (1) · 1283-1288

DOI: 10.1159/000552862 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Case Reports in Oncology, online erschienen am 14.07.2026. Verfasst von Bashaer Alsaati und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, King Abdullah Medical City, Makkah, Saudi Arabia. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Xeroderma pigmentosum (XP) is a rare autosomal recessive DNA repair disorder, resulting from defects in nucleotide excision repair, that predisposes affected individuals to multiple cancers, particularly skin malignancies. Internal tumors including breast cancer are uncommon. Triple-negative breast cancer (TNBC) is an aggressive subtype that presents unique therapeutic challenges, particularly in XP patients where radiotherapy is contraindicated. Case Presentation: We report a 34-year-old woman with XP who presented with a 6-cm right breast mass. Histopathology revealed grade III invasive carcinoma of no special type (NST) ER-negative, PR low positivity (1–2% of cells), HER2-negative (score 0), Ki-67 >80%. BRCA1/2 testing was negative. She underwent four cycles of neoadjuvant doxorubicin/cyclophosphamide with limited response, followed by modified radical mastectomy with axillary lymph node dissection. Pathology confirmed residual 60 mm tumor with negative surgical margins and fifteen negative lymph nodes. Pathological stage: pT3pN0M0 (AJCC 8th edition). She subsequently received adjuvant paclitaxel plus carboplatin. Radiotherapy was omitted due to XP-related radiosensitivity. At 12 months, the patient remained disease-free.

Conclusion

TNBC in XP is exceedingly rare and presents complex management challenges. Platinum-based chemotherapy is biologically rational given the underlying NER defect and may be particularly effective given underlying DNA repair defects, while radiotherapy avoidance necessitates surgical prioritization and PARP inhibitors may represent promising future strategies.

Schlagwörter

Stichwörter der Autor:innen

Carcinoma of no special typeDNA repair deficiencyPlatinum chemotherapyRadiotherapy contraindicationTriple-negative breast cancerXeroderma pigmentosum

Autor:innen und Institutionen

  • Department of Radiation Oncology, King Abdullah Medical City, Makkah, Saudi Arabia.
  • Department of Radiology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Department of Surgery, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Department of Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.

Zitieren

APA

Alsaati, B., Ujaimi, R., Trabulsi, N., & Abusanad, A. (2026). Unusual Presentation of Triple-Negative Breast Cancer in a Young Woman with Xeroderma Pigmentosum: A Case Report. Case Reports in Oncology, 19(1), 1283-1288. https://doi.org/10.1159/000552862

Vancouver

Alsaati B, Ujaimi R, Trabulsi N, Abusanad A. Unusual Presentation of Triple-Negative Breast Cancer in a Young Woman with Xeroderma Pigmentosum: A Case Report. Case Reports in Oncology. 2026;19(1):1283-1288. doi:10.1159/000552862

BibTeX
@article{Alsaati2026,
  author = {Alsaati, Bashaer and Ujaimi, Reem and Trabulsi, Noura and Abusanad, Atlal},
  title = {Unusual Presentation of Triple-Negative Breast Cancer in a Young Woman with Xeroderma Pigmentosum: A Case Report},
  journal = {Case Reports in Oncology},
  year = {2026},
  volume = {19},
  number = {1},
  pages = {1283--1288},
  doi = {10.1159/000552862}
}
Kostenlos starten →